4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001423029-25-000007
Chief Executive Officer sold 26,031 shares at an average $68.04 ($1,771,022)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Anzalone Christopher Richard · Chief Executive Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-19 | Sale : show line 1 in the form 10b5-1 | −3,979 | $66.67 | $265,280 | 3,827,978 | D |
| 2025-12-19 | Sale : show line 2 in the form 10b5-1 | −8,147 | $68.01 | $554,077 | 3,819,831 | D |
| 2025-12-19 | Sale : show line 3 in the form 10b5-1 | −1,319 | $68.48 | $90,325 | 3,818,512 | D |
| 2025-12-22 | Sale : show line 4 in the form 10b5-1 | −10,012 | $68.33 | $684,120 | 3,808,500 | D |
| 2025-12-22 | Sale : show line 5 in the form 10b5-1 | −2,574 | $68.85 | $177,220 | 3,805,926 | D |
| Open-market sales · 26,031 sh · avg $68.04 · $1,771,022 | ||||||
Loading xslF345X05/wk-form4_1766530888.xml…